DAFNA Capital Management »

Keros Therapeutics shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3M 74k 58.07
2024-06-30 $3.1M 68k 45.70
2024-03-31 $4.5M 68k 66.20
2023-12-31 $3.0M 74k 39.76
2023-09-30 $2.1M 66k 31.88
2023-06-30 $1.9M 48k 40.18
2023-03-31 $827k 19k 42.70
2022-12-31 $1.6M 33k 48.02
2022-09-30 $1.5M 39k 37.62
2022-06-30 $1.1M 39k 27.64